Mode of action, toxicity, pharmacokinetics, and efficacy of some new antiherpesvirus guanosine analogs related to buciclovir
about
Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infectionThird trimester antiviral therapy for preventing recurrent genital herpes at deliveryIn vitro activities of penciclovir and acyclovir against herpes simplex virus types 1 and 2Mode of action of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cellsInhibition of varicella-zoster virus-induced DNA polymerase by a new guanosine analog, 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine triphosphatePharmacokinetics and antiviral activity in simian varicella virus-infected monkeys of (R,S)-9-[4-hydroxy-2-(hydroxymethyl) butyl]guanine, an anti-varicella-zoster virus drugAntiherpesvirus activity of 9-(4-hydroxy-3-hydroxymethylbut-1-yl) guanine (BRL 39123) in animalsAntiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell cultureMode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesvirusesMode of action of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl) cycloprop-1'-yl]methyl]guanine (A-5021) against herpes simplex virus type 1 and type 2 and varicella-zoster virus.Susceptibilities of herpes simplex viruses to penciclovir and acyclovir in eight cell lines.Comparative activity of penciclovir and acyclovir in mice infected intraperitoneally with herpes simplex virus type 1 SC16.Differential mutation patterns in thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 clones passaged in the presence of acyclovir or penciclovir.Sensitivity of monkey B virus (Cercopithecine herpesvirus 1) to antiviral drugs: role of thymidine kinase in antiviral activities of substrate analogs and acyclonucleosidesTargeting HGF/c-MET induces cell cycle arrest, DNA damage, and apoptosis for primary effusion lymphomaSingle-day treatment for orolabial and genital herpes: a brief review of pathogenesis and pharmacologyAntiviral Chemistry & Chemotherapy's current antiviral agents FactFile (2nd edition): DNA viruses.Another ten stories in antiviral drug discovery (part C): "Old" and "new" antivirals, strategies, and perspectives.Screening for new agents.Improvement of the absorption of oral (R,S)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine, an anti-varicella-zoster virus drug, in rats and monkeys.Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile (2nd edition): retroviruses and hepadnaviruses.Ribonucleotide reductase represents a novel therapeutic target in primary effusion lymphoma.Structure-activity relationships and conformational features of antiherpetic pyrimidine and purine nucleoside analogues. A review.Thiazolo[4,5-d]pyrimidines. Part II. Synthesis and anti-human cytomegalovirus activity in vitro of certain acyclonucleosides and acyclonucleotides derived from the guanine analogue 5-aminothiazolo[4,5-d]pyrimidine-2,7(3H,6H)-dione.New antiherpes drugs in development
P2860
Q24242853-0518A7C0-2EB7-4127-9E30-EB0335BFAE3EQ24246421-8EB06A20-D5AD-4D4F-A27E-04600D5E352BQ28326891-0EDA5315-BFFD-49EB-A63B-74A0235E87ADQ28342540-72EEB8C3-7EFC-4AA8-890F-0C44F3A65698Q28359883-070FC12D-556E-4A49-8DD2-BC8B232F6ED9Q28359962-E4FFD641-014F-4B63-A49D-0F9B1460A4D0Q28361450-6E90384C-66A3-473D-B55C-1F69926A9BB3Q28361902-FE5889DC-7244-4B71-A3FF-52256E64EAC8Q28367379-81D8C652-AC57-4C9A-A178-C1F3FE821B7DQ28368325-045B6277-16D6-4D0F-BB1A-1240871572DDQ34113580-04DC94AA-741D-4C1D-9AB6-EF25331EB61DQ34729783-DEAF66EB-6A79-4596-8A6B-78253CFBA954Q34938781-7BB0B814-DC85-4105-9170-610A12DECD15Q35840788-E84434EF-7E64-4D77-9B75-99ACE796F0FAQ36406993-6879CAEA-2275-4B73-B7EA-810117554056Q36823598-352E8EF9-7DCD-4C68-B21A-4D84EBA6CC78Q37252268-170232C8-8B8B-4304-AE8D-6D844F19812EQ37406126-E45F2704-8771-4863-8B11-BD5BF0B66133Q37977579-B4B1D40B-3FFE-4264-BC5C-E4EA07EB0C8CQ39814826-00A952F7-3A0E-48DD-8E6A-51105171CA17Q40055204-64563432-6EC0-4CD9-B448-4826EA568650Q40220518-4D8246FC-5591-4C42-884A-4B65BD5D4B7CQ40672683-5A0BDA8C-4DB1-441D-BFEA-C7FEC2A7989BQ40983979-9A0FD0BC-DA71-42E1-AC87-33CA0E623AA9Q56864665-81DE2FE3-F553-46D3-9EF5-3E34E5DFD6A6
P2860
Mode of action, toxicity, pharmacokinetics, and efficacy of some new antiherpesvirus guanosine analogs related to buciclovir
description
1986 nî lūn-bûn
@nan
1986 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Mode of action, toxicity, phar ...... analogs related to buciclovir
@ast
Mode of action, toxicity, phar ...... analogs related to buciclovir
@en
Mode of action, toxicity, phar ...... analogs related to buciclovir
@nl
type
label
Mode of action, toxicity, phar ...... analogs related to buciclovir
@ast
Mode of action, toxicity, phar ...... analogs related to buciclovir
@en
Mode of action, toxicity, phar ...... analogs related to buciclovir
@nl
prefLabel
Mode of action, toxicity, phar ...... analogs related to buciclovir
@ast
Mode of action, toxicity, phar ...... analogs related to buciclovir
@en
Mode of action, toxicity, phar ...... analogs related to buciclovir
@nl
P2093
P2860
P356
P1476
Mode of action, toxicity, phar ...... analogs related to buciclovir
@en
P2093
A C Ericson
K Stenberg
N G Johansson
P2860
P304
P356
10.1128/AAC.30.4.598
P407
P577
1986-10-01T00:00:00Z